Merck KGaA (OTCMKTS:MKGAF) Hits New 12-Month Low – Should You Sell?

Merck KGaA (OTCMKTS:MKGAF) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $116.68 and last traded at $125.0530, with a volume of 372 shares trading hands. The stock had previously closed at $120.51.

Merck KGaA Trading Up 3.8%

The business has a 50 day simple moving average of $145.32 and a two-hundred day simple moving average of $139.78. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock has a market cap of $16.16 billion, a price-to-earnings ratio of 19.09 and a beta of 0.96.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.